The hypolipidemic drug metabolites nafenopin‐CoA and ciprofibroyl‐CoA are competitive P2Y1 receptor antagonists

Simple item page
dc.contributor.authorCoddou, Claudio
dc.contributor.authorBronfman A., Miguel L.
dc.contributor.authorHuidobro-Toro, Juan Pablo
dc.date.accessioned2017-04-25T19:24:23Z
dc.date.available2017-04-25T19:24:23Z
dc.date.issued2003
dc.fechaingreso.objetodigital2025-01-05
dc.identifier.issn0014-5793
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/20294
dc.language.isoen
dc.nota.accesocontenido completo
dc.relation.isformatofFebs Letters Vol. 536, no. 3 (2003), p. [145]-150
dc.revistaFebs Letterses_ES
dc.rightsacceso abierto
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.otherAcil coenzima aes_ES
dc.subject.other Efectos de drogases_ES
dc.subject.otherNafenopino - Farmacologíaes_ES
dc.subject.otherReceptores purinérgicos P2X2es_ES
dc.titleThe hypolipidemic drug metabolites nafenopin‐CoA and ciprofibroyl‐CoA are competitive P2Y1 receptor antagonistses_ES
dc.typeartículo
dc.volumenVol. 536
sipa.codpersvinculados98819
sipa.codpersvinculados98862
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
The hypolipidemic drug metabolites nafenopin‐CoA and ciprofibroyl‐CoA are competitive P2Y1 receptor antagonists.pdf
Size:
227.17 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas